Todd E Heaton1, William J Hammond2, Benjamin A Farber2, Valerie Pallos2, Paul A Meyers3, Alexander J Chou3, Anita P Price4, Michael P LaQuaglia2. 1. Pediatric Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: heatont@mskcc.org. 2. Pediatric Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. 3. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY. 4. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
Abstract
PURPOSE: Cooperative studies support complete metastasectomy in osteosarcoma (OS). Pre-operative CT is used to identify and quantify metastases and can facilitate minimally invasive techniques. Here we assess the accuracy of pre-operative CT compared to findings at thoracotomy and its change over time. METHODS: We reviewed OS thoracotomies performed at our institution from 1996 to 2015. The number of metastases identified on pre-operative chest CT was compared to the number of metastases seen on pathology (both metastases with viable cells and non-viable, osteoid-only metastases). RESULTS: Eighty-eight patients underwent 161 thoracotomies with a median of 14days (range, 1-85) between CT and surgery, a median of 2 CT-identified lesions (range, 0-15), and a median of 4 resected lesions (range, 1-25). In 56 (34.8%) cases, more metastases were found surgically than were seen on CT, and among these, 34 (21.1%) had a greater number of viable metastases. There was poor overall correlation between CT and pathology findings (Kendall Tau-b=0.506), regardless of CT slice thickness, decade of thoracotomy, or total number of CT-identified lesions. CONCLUSIONS: CT accuracy in pre-operatively quantifying OS pulmonary metastases has not improved in recent decades. Consequently, we recommend an open technique with direct lung palpation for complete identification and resection of OS pulmonary metastases. LEVEL OF EVIDENCE: Level IV, retrospective study with no comparison group.
PURPOSE: Cooperative studies support complete metastasectomy in osteosarcoma (OS). Pre-operative CT is used to identify and quantify metastases and can facilitate minimally invasive techniques. Here we assess the accuracy of pre-operative CT compared to findings at thoracotomy and its change over time. METHODS: We reviewed OS thoracotomies performed at our institution from 1996 to 2015. The number of metastases identified on pre-operative chest CT was compared to the number of metastases seen on pathology (both metastases with viable cells and non-viable, osteoid-only metastases). RESULTS: Eighty-eight patients underwent 161 thoracotomies with a median of 14days (range, 1-85) between CT and surgery, a median of 2 CT-identified lesions (range, 0-15), and a median of 4 resected lesions (range, 1-25). In 56 (34.8%) cases, more metastases were found surgically than were seen on CT, and among these, 34 (21.1%) had a greater number of viable metastases. There was poor overall correlation between CT and pathology findings (Kendall Tau-b=0.506), regardless of CT slice thickness, decade of thoracotomy, or total number of CT-identified lesions. CONCLUSIONS: CT accuracy in pre-operatively quantifying OS pulmonary metastases has not improved in recent decades. Consequently, we recommend an open technique with direct lung palpation for complete identification and resection of OS pulmonary metastases. LEVEL OF EVIDENCE: Level IV, retrospective study with no comparison group.
Authors: Mark L Kayton; Andrew G Huvos; Jennifer Casher; Sara J Abramson; Nancy S Rosen; Leonard H Wexler; Paul Meyers; Michael P LaQuaglia Journal: J Pediatr Surg Date: 2006-01 Impact factor: 2.545
Authors: U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam Journal: J Thorac Cardiovasc Surg Date: 1997-01 Impact factor: 5.209
Authors: Israel Fernandez-Pineda; Najat C Daw; Beth McCarville; Liza J Emanus; Bhaskar N Rao; Andrew M Davidoff; Stephen J Shochat Journal: J Pediatr Surg Date: 2012-06 Impact factor: 2.545
Authors: M T Han; R L Telander; P C Pairolero; W S Payne; G S Gilchrist; F H Sim; D J Pritchard Journal: J Pediatr Surg Date: 1981-12 Impact factor: 2.545
Authors: Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier Journal: J Clin Oncol Date: 2008-02-01 Impact factor: 44.544
Authors: A M Goorin; M J Delorey; E E Lack; R D Gelber; K Price; J R Cassady; R Levey; D Tapper; N Jaffe; M Link Journal: J Clin Oncol Date: 1984-05 Impact factor: 44.544
Authors: Emilie P Buddingh; Jakob K Anninga; Michel I M Versteegh; Antonie H M Taminiau; R Maarten Egeler; Catherina S P van Rijswijk; Pancras C W Hogendoorn; Arjan C Lankester; Hans Gelderblom Journal: Pediatr Blood Cancer Date: 2010-02 Impact factor: 3.167
Authors: Susan N Chi; Laurie S Conklin; Jing Qin; Paul A Meyers; Andrew G Huvos; John H Healey; Richard Gorlick Journal: Pediatr Blood Cancer Date: 2004-01 Impact factor: 3.167
Authors: Hans Gelderblom; Rachel C Jinks; Matthew Sydes; Vivien H C Bramwell; Martine van Glabbeke; Robert J Grimer; Pancras C W Hogendoorn; Anne McTiernan; Ian J Lewis; Marianne A Nooij; Antonie H M Taminiau; Jeremy Whelan Journal: Eur J Cancer Date: 2011-01-06 Impact factor: 9.162
Authors: Martha E Teke; Areeba Saif; Amber Leila Sarvestani; Jonathan M Hernandez; Timothy B Lautz; John J Doski Journal: Ann Surg Oncol Date: 2022-09-09 Impact factor: 4.339